Literature DB >> 7253782

Current aspects of immunotherapy in cancer.

.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7253782     DOI: 10.1007/bf01834012

Source DB:  PubMed          Journal:  Langenbecks Arch Chir        ISSN: 0023-8236


× No keyword cloud information.
  9 in total

1.  Specific immunotherapy with neuraminidase-modified leukemic cells: experimental and clinical trials.

Authors:  J G Bekesi; J F Holland; J P Roboz
Journal:  Med Clin North Am       Date:  1977-09       Impact factor: 5.456

2.  Current enigmas in cancer research.

Authors:  L J Old; E A Boyse
Journal:  Harvey Lect       Date:  1973

3.  Occurrence of cancer in immune deficiencies.

Authors:  I Penn
Journal:  Cancer       Date:  1974-09       Impact factor: 6.860

4.  Immunotherapy of malignant melanoma.

Authors:  W D Terry
Journal:  N Engl J Med       Date:  1980-11-13       Impact factor: 91.245

5.  Levamisole in advanced human breast cancer.

Authors:  A F Rojas; J N Feierstein; E Mickiewicz; H Glait; A J Olivari
Journal:  Lancet       Date:  1976-01-31       Impact factor: 79.321

Review 6.  Double-blind levamisole trial in resectable lung cancer.

Authors:  W K Amery
Journal:  Ann N Y Acad Sci       Date:  1976       Impact factor: 5.691

7.  [The cellular immune status in normal subjects, patients with and without neoplasms].

Authors:  M Betzler; H D Flad; P Schlag; C Herfarth
Journal:  Onkologie       Date:  1978-08

8.  BCG immunotherapy as a systemic adjunct to surgery in malignant melanoma.

Authors:  D L Morton; F R Eilber; E C Holmes; F C Sparks; K Ramming
Journal:  Med Clin North Am       Date:  1976-05       Impact factor: 5.456

9.  Analysis of antigenic heterogeneity within individual 3-methylcholanthrene-induced mouse sarcomas.

Authors:  R T Prehn
Journal:  J Natl Cancer Inst       Date:  1970-11       Impact factor: 13.506

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.